Investors are reassessing what it means to be an "AI winner" in the current market, and Baird analyst Colin Sebastian thinks ...
Exchange-traded funds that hold stocks linked to the artificial-intelligence theme were jumping Friday, beating the ...
The group, which houses a stable of brands that includes VW, Audi and Porsche, reported a 6.3% fall in third-quarter revenue to 75.28 billion euros, while the operating loss widened to 5.86 billion ...
Haleon at its half-year results in July said it expected organic revenue growth of 3% to 5%. The British consumer healthcare company's performance was held back by weaker sales in cough, cold and flu ...
Larsen & Toubro Ltd. 500510 shares rallied 3.68% to 3,805.00 Indian rupees Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the BSE SENSEX Index 1 ...
MTU Aero Engines boosted its revenue and cash conversion guidance for the year, citing robust demand in its commercial maintenance business and a more favorable exchange rate between the dollar and ...
Kikusui Electronics Corp. (6912.TO) Japan Half-Year Ended September 30 GROUP 2026 2025 Revenue Y7.65 bln Y6.60 bln Operating Profit Y1.17 bln Y844.00 mln Pretax Profit Y1.26 bln Y959.00 mln Net Profit ...
Takeda Pharmaceutical raised its annual earnings forecasts, after swinging to a net profit in the second quarter. The Japanese drugmaker on Thursday reported net profit of 192.4 billion yen, ...
Nagoya City, Japan Half-Year Ended September 30 GROUP 2026 2025 Revenue Y1.95 tln Y1.75 tln Operating Profit (Y78.05 bln) Y145.54 bln Pretax Profit Y41.05 bln Y196.30 bln Net Profit (Y280.46 bln) Y166 ...
Microsoft’s stock is rising while Alphabet’s is falling, showing how investors are paying more attention to whether AI ...
Japan Half-Year Ended September 30 PARENT 2026 2025 Revenue Y2.11 bln Y2.09 bln Operating Profit Y607.00 mln Y534.00 mln Pretax Profit Y665.00 mln Y604.00 mln Net Profit Y446.00 mln Y410.00 mln Per ...
Thailand's Siam Cement and PTT Global Chemical are forming a petrochemical joint venture valued at over $5 billion, aiming to strengthen their position in an increasingly challenging industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results